AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25186259 — intervention group
Group type: EXPERIMENTAL
Intervention: SPACE FOR COPD (self-management intervention)
Number of subjects: 184
Study 25186259 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 184
Study 21862399 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 0
Study 21862399 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextrometorphane
Number of subjects: 0
Study 21862399 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 0
Study 21862399 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 18561865 — intervention group
Group type: EXPERIMENTAL
Intervention: Cod
Number of subjects: 324
Study 18561865 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmon
Number of subjects: 324
Study 18561865 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil
Number of subjects: 324
Study 18561865 — intervention group
Group type: COMPARATOR
Intervention: No seafood (control)
Number of subjects: 324
Study 17975481 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonselective beta-blockers
Number of subjects: 0
Study 17975481 — intervention group
Group type: EXPERIMENTAL
Intervention: Variceal band ligation
Number of subjects: 0
Study 17975481 — intervention group
Group type: COMPARATOR
Intervention: Beta-blockers
Number of subjects: 0
Study 17975481 — intervention group
Group type: COMPARATOR
Intervention: Organic nitrates
Number of subjects: 0
Study 17975481 — intervention group
Group type: EXPERIMENTAL
Intervention: Band ligation
Number of subjects: 0
Study 15728228 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel/gemcitabine (DG): gemcitabine 1,000 mg/m(2) [days 1 and 8] plus docetaxel 100 mg/m(2) [day 8]
Number of subjects: 413
Study 15728228 — intervention group
Group type: COMPARATOR
Intervention: Vinorelbine/cisplatin (VC): vinorelbine 30 mg/m(2) [days 1 and 8] plus cisplatin 80 mg/m(2) [day 8]
Number of subjects: 413
Study 15728228 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel/gemcitabine (DG)
Number of subjects: 413
Study 15728228 — intervention group
Group type: COMPARATOR
Intervention: Vinorelbine/cisplatin (VC)
Number of subjects: 413
Study 12473800 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified grading of Gram stained smears (grades I, II, III, 0, IV)
Number of subjects: 162
Study 12473800 — intervention group
Group type: EXPERIMENTAL
Intervention: Grade III smear assessment
Number of subjects: 162
Study 12473800 — intervention group
Group type: EXPERIMENTAL
Intervention: Grade I smear assessment
Number of subjects: 162
Study 12473800 — intervention group
Group type: EXPERIMENTAL
Intervention: Grade II smear assessment
Number of subjects: 162
Study 12473800 — intervention group
Group type: EXPERIMENTAL
Intervention: Grades 0 and IV smear assessments
Number of subjects: 162
Study 10402622 — intervention group
Group type: EXPERIMENTAL
Intervention: Client interviewers
Number of subjects: 120
Study 10402622 — intervention group
Group type: COMPARATOR
Intervention: Staff members
Number of subjects: 120
Study 8821071 — intervention group
Group type: EXPERIMENTAL
Intervention: Nootropic drugs
Number of subjects: 61
Study 8821071 — intervention group
Group type: COMPARATOR
Intervention: No additional treatment (nootropics)
Number of subjects: 61
Study 8821071 — intervention group
Group type: EXPERIMENTAL
Intervention: High L-dopa dosage
Number of subjects: 61
Study 8821071 — intervention group
Group type: EXPERIMENTAL
Intervention: Nootropic drugs (responders)
Number of subjects: 61
Study 8821071 — intervention group
Group type: COMPARATOR
Intervention: No additional treatment (non-responders)
Number of subjects: 61
Study 8821071 — intervention group
Group type: COMPARATOR
Intervention: No additional treatment (responders)
Number of subjects: 61
Study 8821071 — intervention group
Group type: EXPERIMENTAL
Intervention: Nootropic drugs (non-responders)
Number of subjects: 61
Study 2166455 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose of inhaled terbutaline (LDT), 500 micrograms four times a day
Number of subjects: 11
Study 2166455 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose of inhaled terbutaline (HDT), 2,000 micrograms four times a day
Number of subjects: 11
Study 2166455 — intervention group
Group type: COMPARATOR
Intervention: Control (ipratropium bromide during run-in and washout periods)
Number of subjects: 11
Study 7219673 — intervention group
Group type: COMPARATOR
Intervention: Dopamine (DA) infusion (5 microgram/kg/min for 120 min)
Number of subjects: 0
Study 7219673 — intervention group
Group type: COMPARATOR
Intervention: L-dopa (500 mg p.o.)
Number of subjects: 0
Study 7219673 — intervention group
Group type: COMPARATOR
Intervention: L-dopa (100 mg p.o.) plus carbidopa (35 mg p.o.) after pretreatment with carbidopa (50 mg p.o. every 6 h for 1 day)
Number of subjects: 0
Study 7219673 — intervention group
Group type: COMPARATOR
Intervention: Nomifensine (200 mg p.o.)
Number of subjects: 0
Study 7219673 — intervention group
Group type: COMPARATOR
Intervention: Control placebo study
Number of subjects: 0
Study 31122969 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin
Number of subjects: 663
Study 31122969 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam
Number of subjects: 663
Study 31122969 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 663
Study 29429912 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab 120 mg subcutaneously every 4 weeks
Number of subjects: 1718
Study 29429912 — intervention group
Group type: COMPARATOR
Intervention: Zoledronic acid 4 mg intravenously every 4 weeks
Number of subjects: 1718
Study 29429912 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 1718
Study 29429912 — intervention group
Group type: COMPARATOR
Intervention: Zoledronic acid
Number of subjects: 1718
Study 26939082 — intervention group
Group type: EXPERIMENTAL
Intervention: Postnatal supplementation with docosahexaenoic acid (DHA) and arachidonic acid (AA)
Number of subjects: 129
Study 26939082 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 129
Study 23458430 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold-water immersion (10 °C; CWI)
Number of subjects: 9
Study 23458430 — intervention group
Group type: COMPARATOR
Intervention: Mixed-method cooling (MIX)
Number of subjects: 9
Study 23458430 — intervention group
Group type: COMPARATOR
Intervention: Control (CONT)
Number of subjects: 9
Study 22828610 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised triage
Number of subjects: 3133
Study 22828610 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerised triage
Number of subjects: 3133
Study 22828610 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 3133
Study 19093122 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 T
Number of subjects: 20
Study 19093122 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 T
Number of subjects: 20
Study 17599307 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF (granulocyte colony-stimulating factor), 263 mu g per day administered intravenously
Number of subjects: 60
Study 17599307 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 17599307 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF (granulocyte colony-stimulating factor)
Number of subjects: 60
Study 14695004 — intervention group
Group type: EXPERIMENTAL
Intervention: Depleted uranium exposed soldiers with embedded shrapnel
Number of subjects: 45
Study 14695004 — intervention group
Group type: EXPERIMENTAL
Intervention: Depleted uranium exposed soldiers with no shrapnel
Number of subjects: 45
Study 14695004 — intervention group
Group type: COMPARATOR
Intervention: Reference group of deployed soldiers not involved in friendly fire incidents
Number of subjects: 45
Study 11845645 — intervention group
Group type: EXPERIMENTAL
Intervention: Factorial analysis of variance (ANOVA)
Number of subjects: 0
Study 11845645 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate analyses of variance (MANOVAs)
Number of subjects: 0
Study 11845645 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple main effects analysis
Number of subjects: 0
Study 11150968 — intervention group
Group type: EXPERIMENTAL
Intervention: Na(+)‐K(+)‐ATPase concentration in CHF males (n=27)
Number of subjects: 34
Study 11150968 — intervention group
Group type: EXPERIMENTAL
Intervention: Na(+)‐K(+)‐ATPase concentration in CHF females (n=7)
Number of subjects: 34
Study 11150968 — intervention group
Group type: EXPERIMENTAL
Intervention: Na(+)‐K(+)‐ATPase concentration in untrained CHF males (n=7)
Number of subjects: 34
Study 11150968 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak aerobic power (VO(2) peak) and Na(+)‐K(+)‐ATPase correlation
Number of subjects: 34
Study 11150968 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak aerobic power (VO(2) peak) and maximal citrate synthase activity correlation
Number of subjects: 34
Study 9508663 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal sodium diet (3 days)
Number of subjects: 56
Study 9508663 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium restriction (30‐40 mmol Na/24 h for 3 days)
Number of subjects: 56
Study 8197850 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodegradable polyglycolic acid (PGA) rods (n=15)
Number of subjects: 32
Study 8197850 — intervention group
Group type: EXPERIMENTAL
Intervention: Screws (n=17)
Number of subjects: 32
Study 8197850 — intervention group
Group type: COMPARATOR
Intervention: Nondegradable osteosynthesis technique (reference group)
Number of subjects: 32
Study 3051432 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted learning program
Number of subjects: 83
Study 3051432 — intervention group
Group type: COMPARATOR
Intervention: Weekly seminars with a cardiologist
Number of subjects: 83
Study 1294383 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous perinatal death
Number of subjects: 1324
Study 1294383 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal diabetes
Number of subjects: 1324
Study 1294383 — intervention group
Group type: EXPERIMENTAL
Intervention: Epilepsy
Number of subjects: 1324
Study 1294383 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydramnios
Number of subjects: 1324
Study 1294383 — intervention group
Group type: EXPERIMENTAL
Intervention: Disproportion between fetus and pelvis
Number of subjects: 1324
Study 1294383 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous spontaneous abortion
Number of subjects: 1324
Study 1294383 — intervention group
Group type: COMPARATOR
Intervention: Involuntary childlessness
Number of subjects: 1324
Study 1294383 — intervention group
Group type: COMPARATOR
Intervention: Contraceptive use
Number of subjects: 1324
Study 1294383 — intervention group
Group type: COMPARATOR
Intervention: Smoking
Number of subjects: 1324
Study 596499 — intervention group
Group type: EXPERIMENTAL
Intervention: Physicians
Number of subjects: 0
Study 596499 — intervention group
Group type: COMPARATOR
Intervention: Nurses
Number of subjects: 0
Study 596499 — intervention group
Group type: EXPERIMENTAL
Intervention: Physicians (IUD users)
Number of subjects: 0
Study 596499 — intervention group
Group type: COMPARATOR
Intervention: Nurses (IUD users)
Number of subjects: 0
Study 596499 — intervention group
Group type: EXPERIMENTAL
Intervention: Physicians (pill users)
Number of subjects: 0
Study 596499 — intervention group
Group type: COMPARATOR
Intervention: Nurses (pill users)
Number of subjects: 0
Study 30461089 — intervention group
Group type: EXPERIMENTAL
Intervention: Both parents being asthmatic
Number of subjects: 806
Study 30461089 — intervention group
Group type: EXPERIMENTAL
Intervention: Only the mother being asthmatic
Number of subjects: 806
Study 30461089 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncontrolled maternal asthma during pregnancy
Number of subjects: 806
Study 30461089 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufficient maternal vitamin D status (25Hydroxyvitamin D ≥ 30 ng/mL) during early and late pregnancy
Number of subjects: 806
Study 29143400 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg intranasal naloxone
Number of subjects: 38
Study 29143400 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg intranasal naloxone
Number of subjects: 38
Study 29143400 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg intranasal naloxone
Number of subjects: 38
Study 29143400 — intervention group
Group type: COMPARATOR
Intervention: 0.4 mg intramuscular naloxone (reference)
Number of subjects: 38
Study 29143400 — intervention group
Group type: COMPARATOR
Intervention: 0.4 mg intravenous naloxone
Number of subjects: 38
Study 29143400 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal naloxone (1 mg, 2 mg, 4 mg)
Number of subjects: 38
Study 29143400 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular naloxone (0.4 mg)
Number of subjects: 38
Study 29143400 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal naloxone
Number of subjects: 38
Study 29143400 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation of repeat dosing (2 x 2 mg i.n. vs 5 x 0.4 mg i.m.)
Number of subjects: 38
Study 25857374 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy education intervention (DVD demonstrating self-efficacy activities, undertaken four times before admission)
Number of subjects: 91
Study 25857374 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 91
Study 25165090 — intervention group
Group type: EXPERIMENTAL
Intervention: Full Education combining a health belief module with a social‐cognitive theory module that provided hands‐on practice installing alarm batteries and using the alarm's hush button
Number of subjects: 436
Study 25165090 — intervention group
Group type: EXPERIMENTAL
Intervention: Hands‐on Practice social‐cognitive module supplemented by typical fire department education
Number of subjects: 436
Study 25165090 — intervention group
Group type: COMPARATOR
Intervention: Current Norm receiving typical fire department education only
Number of subjects: 436
Study 23101743 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipsychotic medication plus parent training (COMB)
Number of subjects: 124
Study 23101743 — intervention group
Group type: COMPARATOR
Intervention: Antipsychotic medication alone (MED)
Number of subjects: 124
Study 23101743 — intervention group
Group type: EXPERIMENTAL
Intervention: COMB group
Number of subjects: 124
Study 23101743 — intervention group
Group type: COMPARATOR
Intervention: MED group
Number of subjects: 124
Study 23101743 — intervention group
Group type: EXPERIMENTAL
Intervention: COMB families
Number of subjects: 124
Study 23101743 — intervention group
Group type: COMPARATOR
Intervention: MED families
Number of subjects: 124
Study 19640231 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice packs
Number of subjects: 60
Study 19640231 — intervention group
Group type: EXPERIMENTAL
Intervention: Analgesia injection
Number of subjects: 60
Study 19640231 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot water immersion
Number of subjects: 60
Study 17200169 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric restriction (CR; 25% reduction in energy intake, n = 12)
Number of subjects: 35
Study 17200169 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric restriction plus exercise (CR+EX; 12.5% reduction in energy intake + 12.5% increase in exercise energy expenditure, n = 12)
Number of subjects: 35
Study 17200169 — intervention group
Group type: COMPARATOR
Intervention: Control (healthy weight maintenance diet, n = 11)
Number of subjects: 35
Study 16048603 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus (Tac)
Number of subjects: 196
Study 16048603 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporin (CyA)
Number of subjects: 196
Study 11884252 — intervention group
Group type: EXPERIMENTAL
Intervention: SonoVue (0.5, 1, 2, and 4 ml)
Number of subjects: 100
Study 11884252 — intervention group
Group type: EXPERIMENTAL
Intervention: SonoVue (cumulative 7.5 ml dose)
Number of subjects: 100
Study 11884252 — intervention group
Group type: EXPERIMENTAL
Intervention: SonoVue (2.0 ml dose)
Number of subjects: 100
Study 11884252 — intervention group
Group type: COMPARATOR
Intervention: Albunex (two injections)
Number of subjects: 100
Study 10211753 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF
Number of subjects: 17
Study 10211753 — intervention group
Group type: EXPERIMENTAL
Intervention: GM-CSF
Number of subjects: 17
Study 7788518 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (4 mg four times daily)
Number of subjects: 105
Study 7788518 — intervention group
Group type: COMPARATOR
Intervention: Sustained release theophylline (maximum daily dose 13 mg/kg)
Number of subjects: 105
Study 2086794 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcuticular technique
Number of subjects: 100
Study 2086794 — intervention group
Group type: COMPARATOR
Intervention: Interrupted transdermal technique
Number of subjects: 100
Study 113095 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexamethylmelamine (HEX) alone
Number of subjects: 98
Study 113095 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexamethylmelamine (HEX) combined with prophylactic pyridoxine
Number of subjects: 98
Study 113095 — intervention group
Group type: COMPARATOR
Intervention: Control group (HEX alone)
Number of subjects: 98
Study 30964423 — intervention group
Group type: EXPERIMENTAL
Intervention: sICM (7.2 g iodine) at 100 kVp
Number of subjects: 200
Study 30964423 — intervention group
Group type: EXPERIMENTAL
Intervention: rICM (5.4 g iodine) at 100 kVp
Number of subjects: 200
Study 30964423 — intervention group
Group type: EXPERIMENTAL
Intervention: sICM at 50 keV
Number of subjects: 200
Study 30964423 — intervention group
Group type: EXPERIMENTAL
Intervention: rICM at 50 keV
Number of subjects: 200
Study 30964423 — intervention group
Group type: COMPARATOR
Intervention: ICM (sICM and rICM)
Number of subjects: 200
Study 30964423 — intervention group
Group type: EXPERIMENTAL
Intervention: sICM and rICM
Number of subjects: 200
Study 30964423 — intervention group
Group type: COMPARATOR
Intervention: BCM
Number of subjects: 200
Study 29268759 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% CHG
Number of subjects: 796
Study 29268759 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0% CHG
Number of subjects: 796
Study 29268759 — intervention group
Group type: COMPARATOR
Intervention: 10% PVI
Number of subjects: 796
Study 29268759 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% CHG vs. PVI
Number of subjects: 796
Study 29268759 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0% CHG vs. PVI
Number of subjects: 796
Study 29268759 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensitivity analysis (0.5% CHG vs. PVI)
Number of subjects: 796
Study 29268759 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensitivity analysis (1.0% CHG vs. PVI)
Number of subjects: 796
Study 29268759 — intervention group
Group type: EXPERIMENTAL
Intervention: CRBSI incidence
Number of subjects: 796
Study 25522928 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-based exercise
Number of subjects: 66
Study 25522928 — intervention group
Group type: COMPARATOR
Intervention: Land-based exercise
Number of subjects: 66
Study 24039176 — intervention group
Group type: EXPERIMENTAL
Intervention: Septal stapler
Number of subjects: 16
Study 24039176 — intervention group
Group type: COMPARATOR
Intervention: Suture closure
Number of subjects: 16
Study 24039176 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 16
Study 21234545 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioabsorbable screws
Number of subjects: 41
Study 21234545 — intervention group
Group type: COMPARATOR
Intervention: Metal interference screws
Number of subjects: 41
Study 19858762 — intervention group
Group type: EXPERIMENTAL
Intervention: MDD treatment (specific treatments not detailed, included pharmacological and cognitive-behavioral therapy)
Number of subjects: 334
Study 19858762 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline substance-related impairment
Number of subjects: 334
Study 19858762 — intervention group
Group type: EXPERIMENTAL
Intervention: High substance-related impairment (≥ 75th percentile)
Number of subjects: 334
Study 19858762 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental depressive symptoms
Number of subjects: 334
Study 19858762 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 week substance-related impairment scores
Number of subjects: 334
Study 19858762 — intervention group
Group type: COMPARATOR
Intervention: Specific treatments (pharmacological or cognitive-behavioral therapy)
Number of subjects: 334
Study 17354027 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous phospholipid (PL) infusion (200 mg/kg) weekly for 8 weeks
Number of subjects: 39
Study 17354027 — intervention group
Group type: COMPARATOR
Intervention: Intravenous placebo infusion
Number of subjects: 39
Study 17354027 — intervention group
Group type: EXPERIMENTAL
Intervention: Operated carotid (after endarterectomy)
Number of subjects: 39
Study 17354027 — intervention group
Group type: EXPERIMENTAL
Intervention: Unoperated carotid
Number of subjects: 39
Study 15466720 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 438
Study 15466720 — intervention group
Group type: COMPARATOR
Intervention: Brace treatment
Number of subjects: 438
Study 15466720 — intervention group
Group type: COMPARATOR
Intervention: Range-of-motion exercises
Number of subjects: 438
Study 15466720 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral osteotomy
Number of subjects: 438
Study 15466720 — intervention group
Group type: EXPERIMENTAL
Intervention: Innominate osteotomy
Number of subjects: 438
Study 15466720 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment (for lateral pillar B and B/C border groups)
Number of subjects: 438
Study 15466720 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment (for lateral pillar B and B/C border groups)
Number of subjects: 438
Study 15466720 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment (for lateral pillar group C)
Number of subjects: 438
Study 15466720 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment (for lateral pillar group C)
Number of subjects: 438
Study 15466720 — intervention group
Group type: EXPERIMENTAL
Intervention: Age at onset > 8.0 years
Number of subjects: 438
Study 15466720 — intervention group
Group type: EXPERIMENTAL
Intervention: Age at onset <= 8.0 years
Number of subjects: 438
Study 15466720 — intervention group
Group type: EXPERIMENTAL
Intervention: Female patients over 8.0 years
Number of subjects: 438
Study 12102158 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer delays in diagnosis and treatment
Number of subjects: 0
Study 12102158 — intervention group
Group type: COMPARATOR
Intervention: Shorter waiting times in diagnosis and treatment
Number of subjects: 0